Form 4: John Paulson Acquires Additional Shares of Bausch Health Companies Inc.
SEC Form 4 Filing
Director John Paulson reports the acquisition of 5,890 common shares of Bausch Health Companies Inc. at a price of $10.61 per share on March 29, 2024.
Summary
- On March 29, 2024, John Paulson, a director of Bausch Health Companies Inc., acquired 5,890 common shares of the company.
- The shares were purchased at a price of $10.61 per share.
- Following the transaction, Paulson's direct ownership in Bausch Health Companies Inc. amounts to 208,309 common shares.
- The acquisition was reported on April 1, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's purchase suggests confidence, but it's a single transaction and doesn't provide a comprehensive view.
Positives
- The acquisition of shares by a director could be interpreted as a sign of confidence in the company's future prospects.
Industry Context
This filing reflects insider trading activity, which is closely monitored by regulators and investors for insights into a company's prospects. Insider buying can be seen as a positive signal.
Stakeholder Impact
- The acquisition of shares by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/29/2024 | Date of transaction: John Paulson acquired shares of Bausch Health Companies Inc. |
| 04/01/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.